Ind-Swift Laboratories Limited (INDSWFTLAB) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.015x

Based on the latest financial reports, Ind-Swift Laboratories Limited (INDSWFTLAB) has a cash flow conversion efficiency ratio of -0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-202.50 Million ≈ $-2.19 Million USD) by net assets (Rs13.07 Billion ≈ $141.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Ind-Swift Laboratories Limited net asset quality index to measure how much of total assets are equity-financed.

Ind-Swift Laboratories Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Ind-Swift Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Ind-Swift Laboratories Limited (INDSWFTLAB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Ind-Swift Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ind-Swift Laboratories Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Imexpharm Corp
VN:IMP
0.044x
Old Point Financial Corporation
NASDAQ:OPOF
0.014x
Community Bancorp. Common Stock
NASDAQ:CMTV
0.035x
Ontex Group NV
BR:ONTEX
0.072x
Anhui Yuanchen Environmental Protection Science & Technology Co. Ltd.
SHG:688659
0.002x
Caswell Inc
TW:6416
-0.038x
Awfis Space Solutions Ltd
NSE:AWFIS
0.565x
Kimteks Poliuretan Sanayi ve Ticaret AS
IS:KMPUR
0.157x

Annual Cash Flow Conversion Efficiency for Ind-Swift Laboratories Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Ind-Swift Laboratories Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see Ind-Swift Laboratories Limited (INDSWFTLAB) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs11.73 Billion
≈ $126.85 Million
Rs-254.74 Million
≈ $-2.75 Million
-0.022x +89.19%
2024-03-31 Rs8.12 Billion
≈ $87.82 Million
Rs-1.63 Billion
≈ $-17.64 Million
-0.201x -170.38%
2023-03-31 Rs6.82 Billion
≈ $73.75 Million
Rs1.95 Billion
≈ $21.05 Million
0.285x +14.11%
2022-03-31 Rs6.01 Billion
≈ $64.98 Million
Rs1.50 Billion
≈ $16.25 Million
0.250x +11.83%
2021-03-31 Rs6.03 Billion
≈ $65.26 Million
Rs1.35 Billion
≈ $14.59 Million
0.224x +14.40%
2020-03-31 Rs6.41 Billion
≈ $69.28 Million
Rs1.25 Billion
≈ $13.54 Million
0.195x +278.44%
2019-03-31 Rs5.88 Billion
≈ $63.57 Million
Rs-644.00 Million
≈ $-6.96 Million
-0.110x -182.93%
2018-03-31 Rs5.53 Billion
≈ $59.83 Million
Rs730.90 Million
≈ $7.90 Million
0.132x -26.55%
2017-03-31 Rs5.31 Billion
≈ $57.46 Million
Rs955.66 Million
≈ $10.34 Million
0.180x +17.17%
2016-03-31 Rs5.17 Billion
≈ $55.96 Million
Rs794.30 Million
≈ $8.59 Million
0.154x -7.25%
2015-03-31 Rs5.95 Billion
≈ $64.30 Million
Rs983.98 Million
≈ $10.64 Million
0.166x +83.17%
2014-03-31 Rs7.25 Billion
≈ $78.43 Million
Rs655.29 Million
≈ $7.09 Million
0.090x +265.47%
2013-03-31 Rs8.53 Billion
≈ $92.30 Million
Rs-466.03 Million
≈ $-5.04 Million
-0.055x -161.11%
2012-03-31 Rs8.12 Billion
≈ $87.78 Million
Rs725.24 Million
≈ $7.84 Million
0.089x +193.19%
2011-03-31 Rs5.84 Billion
≈ $63.10 Million
Rs177.83 Million
≈ $1.92 Million
0.030x -69.08%
2010-03-31 Rs4.48 Billion
≈ $48.48 Million
Rs441.84 Million
≈ $4.78 Million
0.099x -64.25%
2009-03-31 Rs3.63 Billion
≈ $39.27 Million
Rs1.00 Billion
≈ $10.83 Million
0.276x +61.91%
2008-03-31 Rs3.33 Billion
≈ $36.06 Million
Rs567.77 Million
≈ $6.14 Million
0.170x +17.18%
2007-03-31 Rs3.11 Billion
≈ $33.68 Million
Rs452.62 Million
≈ $4.89 Million
0.145x +137.58%
2006-03-31 Rs1.92 Billion
≈ $20.80 Million
Rs117.63 Million
≈ $1.27 Million
0.061x --

About Ind-Swift Laboratories Limited

NSE:INDSWFTLAB India Drug Manufacturers - Specialty & Generic
Market Cap
$214.71 Million
Rs19.85 Billion INR
Market Cap Rank
#16251 Global
#850 in India
Share Price
Rs228.63
Change (1 day)
+1.94%
52-Week Range
Rs88.15 - Rs246.44
All Time High
Rs246.44
About

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally. The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson's disease, hy… Read more